Home › Nausea and Vomiting › District of Columbia
Nausea and Vomiting clinical trials in District of Columbia
3 studies for Nausea and Vomiting are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Washington DC, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.